Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study
Authors:
- 19 June 2018
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 41 (12) , 1417-1423
Abstract
It has been suggested that high cholesterol represents a risk factor for Graves’ orbitopathy (GO). In a recent cross-sectional study, a correlation between cholesterol and the presence of GO was found in patients with a Graves’ disease (GD) of recent onset. To confirm this observation, we conducted a retrospective investigation in consecutive patients with GD. The primary outcome was the relationship between the presence of GO and low-density lipoprotein (LDL)-cholesterol.Keywords
This publication has 28 references indexed in Scilit:
- Risk Factors for Developing Thyroid-Associated Ophthalmopathy Among Individuals With Graves DiseaseJAMA Ophthalmology, 2015
- Role of genetic and non-genetic factors in the etiology of Graves’ diseaseJournal of Endocrinological Investigation, 2014
- Diet Induced Mild Hypercholesterolemia in Pigs: Local and Systemic Inflammation, Effects on Vascular Injury – Rescue by High-Dose Statin TreatmentPLOS ONE, 2013
- Smoking and thyroidClinical Endocrinology, 2013
- The Evaluation and Treatment of Graves OphthalmopathyMedical Clinics of North America, 2012
- Thyroid-Associated Ophthalmopathy after Treatment for Graves’ Hyperthyroidism with Antithyroid Drugs or Iodine-131The Journal of Clinical Endocrinology & Metabolism, 2009
- Exophthalmometric Values in a Normal Turkish Population Living in the Northeastern Part of TurkeyThyroid®, 2007
- Effects of Total Thyroid Ablation Versus Near-Total Thyroidectomy Alone on Mild to Moderate Graves’ Orbitopathy Treated with Intravenous GlucocorticoidsThe Journal of Clinical Endocrinology & Metabolism, 2007
- Reliability of exophthalmos measurement and the exophthalmometry value distribution in a healthy Dutch population and in Graves' patients. An exploratory studyOrbit, 2004
- Relation between Therapy for Hyperthyroidism and the Course of Graves' OphthalmopathyNew England Journal of Medicine, 1998